Comparison between two different dosages of remifentanil administered by a patient controlled tecnique (PCSA) for diagnostic and andoscopich procedures. - ND

• Conditions: patients affected by patologies to be submitted to endoscopic investigation; MedDRA version: 9.1Level: LLTClassification code 10014805Term: Endoscopy

• Registration Number: EUCTR2009-010383-42-IT
• Lead Sponsor: OSPEDALE S. RAFFAELE

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-03-31
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

patients aged more than 18 years old; ASA physical status I-II;patients candidate for diagnostic or operative intervention of endoscopic type on gastrointestinal tract.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

patients aged under 18 years old; pregnancy fenmale patients.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified